Busiest year for pharmacy based fitness-to-practise hearings

The Pharmaceutical Society of Ireland (PSI) will launch its annual report today and is expected to address issues surrounding legal costs associated with the fitness-to-practise inquiries, after the actual legal expenditure last year was close to double the budgeted amount.
A report in the most recent issue of the IPU Review, a journal produced by the Irish Pharmaceutical Union, detailed a meeting of the PSI Council in July in which its administration and finance committee chairman said the legal costs “screamed out of the page”.